IFNB1 and viral infectious disease: These data revealed that carvedilol positively regulated IFN-β signaling and antiviral immunity by preventing the degradation of β-arrestin 2 and promoting the deacetylation of β-arrestin 2 at Lys171, thus indicating that β-arrestin 2 could be a novel drug candidate for the treatment of virus infection.